PAULA
ORTIZ SÁNCHEZ
Investigadora en el periodo 2020-2023
Hospital Universitario Puerta de Hierro
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (6)
2021
-
The SRSF4-GAS5-Glucocorticoid Receptor Axis Regulates Ventricular Hypertrophy
Circulation Research, Vol. 129, Núm. 6, pp. 669-683
2019
-
Loss of SRSF3 in cardiomyocytes leads to decapping of contraction-related mRNAs and severe systolic dysfunction
Circulation Research, Vol. 125, Núm. 2, pp. 170-183
-
Severe Cardiac Dysfunction and Death Caused by Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Are Improved by Inhibition of Glycogen Synthase Kinase-3β
Circulation, Vol. 140, Núm. 14, pp. 1188-1204
2018
-
Activation of Serine One-Carbon Metabolism by Calcineurin Aβ1 Reduces Myocardial Hypertrophy and Improves Ventricular Function
Journal of the American College of Cardiology, Vol. 71, Núm. 6, pp. 654-667
2016
-
The Calcineurin Variant CnAβ1 Controls Mouse Embryonic Stem Cell Differentiation by Directing mTORC2 Membrane Localization and Activation
Cell Chemical Biology, Vol. 23, Núm. 11, pp. 1372-1382
2014
-
Induction of the calcineurin variant CnAβ1 after myocardial infarction reduces post-infarction ventricular remodelling by promoting infarct vascularization
Cardiovascular Research, Vol. 102, Núm. 3, pp. 396-406